Market Cap 3.03B
Revenue (ttm) 0.00
Net Income (ttm) -109.36M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.05
Volume 554,200
Avg Vol 482,736
Day's Range N/A - N/A
Shares Out 34.77M
Stochastic %K 90%
Beta 0.79
Analysts Strong Sell
Price Target $115.92

Company Profile

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeost...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 674 9274
Address:
321 Arsenal Street, Suite 101, Watertown, United States
PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:31 AM
$IRON is currently trading at $87.04. The RSI at 53.02 indicates a neutral momentum, suggesting no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 81.29 and the 50-day moving average (MA50) of 73.69, indicating a bullish trend in the short to medium term. The recent high of 95.95 and low of 57.99 over the last 60 days suggests a significant range, providing room for upward movement. Directional bias is bullish due to the price being above key moving averages and the neutral RSI, which could support further gains. Suggested entry is at $87.50, with a stop loss at $83.50 to manage risk. Target 1 is set at $92.00, near the recent high, and Target 2 at $95.00, allowing for potential profit-taking as momentum builds. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:04 AM
$IRON is currently trading at $87.04. The RSI at 53.02 indicates a neutral momentum, suggesting no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 81.29 and the 50-day moving average (MA50) of 73.69, indicating a bullish trend in the short to medium term. The recent high of 95.95 and low of 57.99 over the last 60 days suggests a significant range, providing room for upward movement. Directional bias is bullish due to the price being above key moving averages and the neutral RSI, which could support further gains. Suggested entry is at $87.50, with a stop loss at $83.50 to manage risk. Target 1 is set at $92.00, near the recent high, and Target 2 at $95.00, allowing for potential profit-taking as momentum builds. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:10 AM
$IRON: The last close at $86.07 indicates a position above the 30-day moving average (MA30) of $79.96 and the 50-day moving average (MA50) of $72.67, suggesting a bullish trend. The RSI at 47.93 indicates neutral momentum, with potential for upward movement as it approaches the 50 level. The recent high of $95.95 and low of $57.54 over the past 60 days further reflect a significant range, allowing for potential price appreciation. Directional bias is cautiously bullish, supported by the price being above key MAs and the potential for a rebound from the neutral RSI level. Suggested entry: $86.50 (above the last close). Stop: $83.50 (below recent support). Targets: $92.00 (near the 60D high) and $95.00 (psychological resistance). Monitor for any changes in momentum or market conditions. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:46 AM
$IRON: The last close at $86.07 indicates a position above the 30-day moving average (MA30) of $79.96 and the 50-day moving average (MA50) of $72.67, suggesting a bullish trend. The RSI at 47.93 indicates neutral momentum, with potential for upward movement as it approaches the 50 level. The recent high of $95.95 and low of $57.54 over the past 60 days further reflect a significant range, allowing for potential price appreciation. Directional bias is cautiously bullish, supported by the price being above key MAs and the potential for a rebound from the neutral RSI level. Suggested entry: $86.50 (above the last close). Stop: $83.50 (below recent support). Targets: $92.00 (near the 60D high) and $95.00 (psychological resistance). Monitor for any changes in momentum or market conditions. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:19 PM
$IRON Buy Truist Securities raises target price to $114 from $86
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 4:23 PM
Truist Securities has updated their rating for Disc Medicine ( $IRON ) to Buy with a price target of 114.
0 · Reply
Braindead83
Braindead83 Nov. 8 at 4:57 PM
$IRON thoughts? Good but not great
2 · Reply
Braindead83
Braindead83 Nov. 8 at 4:25 PM
$IRON anyone have the ASN data from 11am eastern today?
0 · Reply
Love_To_Learn
Love_To_Learn Nov. 7 at 1:05 PM
$VRTX $IRON require u due to r CELL theme coding for markets
0 · Reply
d_risk
d_risk Nov. 6 at 4:46 PM
$IRON - Disc Medicine Inc. Common Stock - 10Q - Updated Risk Factors IRON’s 10-Q risk factors for 2025 spotlight its limited operating history, rising net losses, and ongoing R&D-to-commercialization challenges; risks now detail open-label trial biases, reliance on single-source suppliers, expanded tax and internal control vulnerabilities, new fraud and management growth risks, and potential stock price hits from insider sales and analyst coverage. #Biotechnology #CorporateGovernance #SupplyChain #FinancialRisk #R&DChallenges 🟢 Added 🟠 Removed https://d-risk.ai/IRON/10-Q/2025-11-06
0 · Reply
Latest News on IRON
Disc Medicine to Participate in Upcoming Investor Conferences

Oct 31, 2025, 8:30 AM EDT - 14 days ago

Disc Medicine to Participate in Upcoming Investor Conferences


Disc Medicine Appoints Nadim Ahmed to its Board of Directors

Jul 14, 2025, 8:30 AM EDT - 4 months ago

Disc Medicine Appoints Nadim Ahmed to its Board of Directors


Disc Medicine: Forging Ahead In Hematology

Apr 9, 2025, 7:13 AM EDT - 7 months ago

Disc Medicine: Forging Ahead In Hematology


Disc Medicine Announces Underwritten Offering of Common Stock

Jun 14, 2024, 8:03 AM EDT - 1 year ago

Disc Medicine Announces Underwritten Offering of Common Stock


FDA Grants Orphan Drug Designation to 9MW3011

Feb 20, 2024, 9:00 AM EST - 1 year ago

FDA Grants Orphan Drug Designation to 9MW3011


PrivateProfiteer
PrivateProfiteer Nov. 15 at 1:31 AM
$IRON is currently trading at $87.04. The RSI at 53.02 indicates a neutral momentum, suggesting no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 81.29 and the 50-day moving average (MA50) of 73.69, indicating a bullish trend in the short to medium term. The recent high of 95.95 and low of 57.99 over the last 60 days suggests a significant range, providing room for upward movement. Directional bias is bullish due to the price being above key moving averages and the neutral RSI, which could support further gains. Suggested entry is at $87.50, with a stop loss at $83.50 to manage risk. Target 1 is set at $92.00, near the recent high, and Target 2 at $95.00, allowing for potential profit-taking as momentum builds. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 14 at 5:04 AM
$IRON is currently trading at $87.04. The RSI at 53.02 indicates a neutral momentum, suggesting no immediate overbought or oversold conditions. The price is above the 30-day moving average (MA30) of 81.29 and the 50-day moving average (MA50) of 73.69, indicating a bullish trend in the short to medium term. The recent high of 95.95 and low of 57.99 over the last 60 days suggests a significant range, providing room for upward movement. Directional bias is bullish due to the price being above key moving averages and the neutral RSI, which could support further gains. Suggested entry is at $87.50, with a stop loss at $83.50 to manage risk. Target 1 is set at $92.00, near the recent high, and Target 2 at $95.00, allowing for potential profit-taking as momentum builds. For further insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 3:10 AM
$IRON: The last close at $86.07 indicates a position above the 30-day moving average (MA30) of $79.96 and the 50-day moving average (MA50) of $72.67, suggesting a bullish trend. The RSI at 47.93 indicates neutral momentum, with potential for upward movement as it approaches the 50 level. The recent high of $95.95 and low of $57.54 over the past 60 days further reflect a significant range, allowing for potential price appreciation. Directional bias is cautiously bullish, supported by the price being above key MAs and the potential for a rebound from the neutral RSI level. Suggested entry: $86.50 (above the last close). Stop: $83.50 (below recent support). Targets: $92.00 (near the 60D high) and $95.00 (psychological resistance). Monitor for any changes in momentum or market conditions. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 2:46 AM
$IRON: The last close at $86.07 indicates a position above the 30-day moving average (MA30) of $79.96 and the 50-day moving average (MA50) of $72.67, suggesting a bullish trend. The RSI at 47.93 indicates neutral momentum, with potential for upward movement as it approaches the 50 level. The recent high of $95.95 and low of $57.54 over the past 60 days further reflect a significant range, allowing for potential price appreciation. Directional bias is cautiously bullish, supported by the price being above key MAs and the potential for a rebound from the neutral RSI level. Suggested entry: $86.50 (above the last close). Stop: $83.50 (below recent support). Targets: $92.00 (near the 60D high) and $95.00 (psychological resistance). Monitor for any changes in momentum or market conditions. https://privateprofiteers.com
0 · Reply
IN0V8
IN0V8 Nov. 10 at 5:19 PM
$IRON Buy Truist Securities raises target price to $114 from $86
0 · Reply
JarvisFlow
JarvisFlow Nov. 10 at 4:23 PM
Truist Securities has updated their rating for Disc Medicine ( $IRON ) to Buy with a price target of 114.
0 · Reply
Braindead83
Braindead83 Nov. 8 at 4:57 PM
$IRON thoughts? Good but not great
2 · Reply
Braindead83
Braindead83 Nov. 8 at 4:25 PM
$IRON anyone have the ASN data from 11am eastern today?
0 · Reply
Love_To_Learn
Love_To_Learn Nov. 7 at 1:05 PM
$VRTX $IRON require u due to r CELL theme coding for markets
0 · Reply
d_risk
d_risk Nov. 6 at 4:46 PM
$IRON - Disc Medicine Inc. Common Stock - 10Q - Updated Risk Factors IRON’s 10-Q risk factors for 2025 spotlight its limited operating history, rising net losses, and ongoing R&D-to-commercialization challenges; risks now detail open-label trial biases, reliance on single-source suppliers, expanded tax and internal control vulnerabilities, new fraud and management growth risks, and potential stock price hits from insider sales and analyst coverage. #Biotechnology #CorporateGovernance #SupplyChain #FinancialRisk #R&DChallenges 🟢 Added 🟠 Removed https://d-risk.ai/IRON/10-Q/2025-11-06
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 12:28 PM
Stifel has updated their rating for Disc Medicine ( $IRON ) to Buy with a price target of 125.
0 · Reply
IN0V8
IN0V8 Oct. 24 at 7:24 PM
$IRON Buy Jefferies raises target price to $127 from $111
0 · Reply
jamonda
jamonda Oct. 22 at 5:26 PM
In case anyone missed it. $IRON offering priced at $84.00 1. Company sold 2,619,049 shares + 59,523 pre-funded warrants (ex. price $0.0001) 2. Selling shareholders sold 297,619 shares 3. Underwriters exercised full over-allotment (446,428 shares) on Oct 21, 2025 Net new (dilutive): ~2.679M shares (including warrants when exercised) Secondary: ~744k shares Total to public: ~3.363M shares + 59.5k warrants From: https://ir.discmedicine.com/static-files/57f167cc-4582-44c0-a1c6-520a7edcb2a9
1 · Reply
Strangperson
Strangperson Oct. 22 at 4:04 PM
$IRON my only green stock. Guess I should have bought bynd 😆
0 · Reply
S_Franconi
S_Franconi Oct. 21 at 3:51 PM
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-announces-proposed-public-offering-common-stock-1
0 · Reply
S_Franconi
S_Franconi Oct. 20 at 1:26 PM
$IRON Disc Medicine Provides Update on Hematology Portfolio and Outlines Near-Term Business Objectives and Anticipated Milestones https://ir.discmedicine.com/news-releases/news-release-details/disc-medicine-provides-update-hematology-portfolio-and-outlines
0 · Reply
OpenOutcrier
OpenOutcrier Oct. 20 at 12:52 PM
$IRON (-2.7% pre) Disc Medicine announces $220M public stock offering https://ooc.bz/l/81184
0 · Reply
StockBraker
StockBraker Oct. 20 at 11:06 AM
$IRON Disc Medicine announces proposed public offering of common stock and pre-funded warrants
0 · Reply
fallondpicks
fallondpicks Oct. 19 at 9:42 PM
19 #stockbreakouts $IRON (gap), $LBRT (base and 200-day MA), $ACHV (gap). Two sub-$1, five $1-2.
2 · Reply
RunnerSignals
RunnerSignals Oct. 17 at 8:22 PM
Top Movers!​ $ACHV $IRON flying on FDA vouchers $BYND buying time with debt swap while $AGH quietly climbing day 5 https://stocksrunner.com/news/2025-10-17-top-movers-and-shakers-making-waves-in-today-trading-session
0 · Reply
MaverikIT
MaverikIT Oct. 17 at 8:12 PM
@IsabellaDC @TheLongVol @Wigglyick been taking your $IRON sup?
1 · Reply